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An increasing incidence of testicular cancer has
been reported from several western countries
during the last decades (Toppari et al. 1995,
1996). In Sweden the annual age-adjusted inci-
dence of testicular cancer increased signiﬁcantly
by 2.2% from 1980 to 1999 (National Board
of Health and Welfare 2001). It is the most
common cancer among young males. Tes-
ticular cancer has usually not been regarded as
an occupational disease (Hardell et al. 1998),
but cryptorchidism is an established risk factor.
An increased risk has also been reported for the
contralateral descendent testis (Henderson et al.
1979), suggesting common risk factors. Some
prenatal risk factors seem to be common for
both cryptorchidism and testicular cancer, such
as high levels of estrogen in the ﬁrst trimester
(Bernstein et al. 1988; Cosgrove et al. 1977).
Prenatal exposures have been suggested to
be of etiologic significance, such as environ-
mental pollutants with estrogen potency, i.e.,
xenoestrogens (Toppari et al. 1995, 1996). In
this context the so-called estrogen hypothesis
has been expanded to include environmental
antiandrogens as endocrine disruptors with
potential adverse effects on male reproductive
health (Skakkebæk et al. 2001; Toppari et al.
1996). Impacts of increasing levels of xenoe-
strogens have been observed in aquatic sys-
tems (Colborn et al. 1993). In humans,
concern has been focused on endocrine-
disrupting chemicals with either estrogenic or
antiestrogenic effects, which may be related to
an increasing incidence of hypospadia in
newborn boys (Dolk 1998; Paulozzi 1999).
Indications of a decrease in sperm counts
have been observed in recent years, but the
hypothesis of an association with exposure to
xenoestrogens is still a controversial question
(Jensen et al. 1995).
Our aim in this study was to investigate
concentrations of certain persistent organic
pollutants (POPs) in blood from men with
testicular cancer compared with controls, and
in mothers to cases compared with mothers
to controls. Informed consent was obtained
from all study persons. The study was
approved by all involved ethical committees.
Materials and Methods
Incident cases with testicular cancer were
recruited from 1997 to 2000 from the
Department of Urology at Huddinge (n = 17)
and Karolinska Hospital in Stockholm (n = 5),
and the Departments of Oncology at the
University Hospitals in Örebro (n = 13),
Linköping (n = 13), and Lund (n = 10),
Sweden. Patients were asked to participate by
their respective physician. No case refused to
participate. Of course, these patients did not
represent all cases with testicular cancer
admitted to these hospitals during this time.
However, no selection bias occurred because
the physicians treated patients regardless of
tumor type. The patient, as well as his
mother, was asked to give blood for chemical
analysis of POPs.
For each case a control subject free from
testicular cancer was drawn from the Swedish
population registry (Stockholm, Sweden).
This national registry covers the whole popu-
lation and is updated continuously with emi-
gration and death data, for example. Because
of unique Swedish personal identification
numbers, all inhabitants can be traced. The
controls were drawn within 5-year age strata
to the cases, for example, 20–24 years, 25–29
years, and randomly selected from all who
qualiﬁed. Thereafter, the mother of the con-
trol subject was identified using the popula-
tion registry. As one criterion, the mother was
to be within the same 5-year age stratum as
the mother to the respective case. If this was
not the situation, a new set of controls, male
control and his mother, was drawn. Both the
male cases and controls and the mothers were
within the same 5-year groups, respectively.
Of the primarily included controls, 15 refused
to participate, and each was replaced by the
next randomly selected subject.
Blood was drawn from all study subjects
during the same period (1997–2000). Study
subjects were instructed to have only a light
meal before this was done. Blood samples from
cases were obtained before start of treatment
with chemotherapy or radiotherapy. The sam-
ple was frozen for later analysis. Furthermore,
all study participants were asked to answer a
questionnaire, for example, on occupations,
weight (present and 1 year previously) and
length before blood was drawn. The mothers
also answered questions on reproductive his-
tory, such as number of children and year of
birth of each child. Duration of breast-feeding
was assessed for the investigated child and all
other children, if any.
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An increasing incidence of testicular cancer has been reported from several countries in the Western
world during the last decades. According to current hypothesis, testicular cancer is initiated during
the fetal period, and exposure to endocrine disruptors, i.e., xenoestrogens, has been of concern. In
this investigation we studied the concentrations of the sum of 38 polychlorinated biphenyls (PCBs),
p,p´-dichlorodiphenyl-dichloroethylene, hexachlorobenzene (HCB), and chlordanes, in 61 cases with
testicular cancer and 58 age-matched controls. Furthermore, case and control mothers were also
asked to participate, and 44 case mothers and 45 control mothers agreed. They were of similar age.
In cases only the concentration on lipid basis of cis-nonachlordane was significantly increased,
whereas case mothers showed significantly increased concentrations of the sum of PCBs, HCB,
trans- and cis-nonachlordane, and the sum of chlordanes. Among case mothers the sum of PCBs
yielded an odds ratio (OR) of 3.8; 95% conﬁdence interval (CI), 1.4–10 was calculated using the
median concentration for the control mothers as cutoff value. For HCB, OR = 4.4 (95% CI,
1.7–12); for trans-nonachlordane, OR = 4.1 (95% CI, 1.5–11); for cis-nonachlordane, OR = 3.1
(95% CI, 1.2–7.8); and for sum of chlordanes, OR = 1.9 (95% CI, 0.7–5.0). No consistent different
risk pattern was found for seminoma or nonseminoma testicular cancer. Key words: chlordanes, fetal
period, hexachlorobenzene, persistent organic pollutants, polychlorinated biphenyls, testicular can-
cer. Environ Health Perspect 111:930–934 (2003). doi:10.1289/ehp.5816 available via
http://dx.doi.org/ [Online 19 December 2002]Chemical analysis. All blood samples were
coded with an identiﬁcation number that did
not reveal sex or whether it was a case or a
control. Approximately 20 mL of blood was
used for analyses of 38 congeners of polychlo-
rinated biphenyls (PCBs) most abundant in
human samples. The sum of these 38 con-
geners is presented here in addition to p,p´-
dichlorodiphenyl-dichloroethylene
(p,p´-DDE), hexachlorobenzene (HCB), and
six chlordane congeners (cis-heptachlordane,
cis-chlordane, oxychlordane, MC6, trans-
nonachlordane, cis-nonachlordane). The
plasma samples were fortified with 13C-
labeled internal standards. The lipid fraction,
containing the organochlorines, was first
removed from blood by use of a Hydromatrix
column (Varian, Palo Alto, CA, USA). The
lipid content was then determined gravimetri-
cally, and lipids and interferences were
removed by multilayer silica chromatography.
Congener-speciﬁc analyses and quantiﬁcation
of the organochlorines was done by high-reso-
lution gas chromatography and coupled mass
spectrometry running in electro impact (EI)
and selected ion monitoring (SIM) mode. The
two most abundant ions of the chlorine cluster
of the molecular ion for each compound were
measured in addition to the one ion for the 12
13C-labeled internal standards (IS) and the
three recovery standards (RS). We used a
quantiﬁcation mix including all compounds in
addition to the IS and RS to calculate relative
response factors (RRFs), and then used these
RRFs to calculate the levels in the samples. In
addition, the recovery of the IS was calculated.
All recoveries of the 12 different IS were
between 50 and 120%. In addition, one labo-
ratory blank sample was processed with each
set of nine samples. All blank levels were
< 10% of the levels reported for all com-
pounds. The methods detection level deﬁned
with a signal-to-noise (S/N) ratio > 3 was in
the range of 0.3–1 ng/g, depending on the
compound and the amount of sample. All
results are expressed in nanograms per gram
lipid. External quality assurance/quality con-
trol was assured by successfully participating in
international round robin or intercalibration
studies organized by both Arctic Monitoring
and Assessment Program (AMAP) and
International Union for Pure and Applied
Chemicals (IUPAC). If some of the PCB
congeners were under the detection limit
(n.d.), 50% of the detection limit was used.
However, for the sum of PCBs, chlordanes,
HCB, and p,p´-DDE, all analytes were above
detection limit.
Statistical methods. We performed uncon-
ditional logistic regression analysis using the
SAS program (SAS Institute, Cary, NC, USA)
for calculation of odds ratio (OR) and 95%
confidence interval (CI). In the analyses, we
adjusted for age and body mass index (BMI) at
the time of sampling. We also adjusted for
BMI 1 year before that time, but observed sim-
ilar results without any signiﬁcant differences,
so the results are presented with adjustment for
BMI at the time of blood sampling. We also
adjusted for lactation of the respective child in
one analysis and for the whole lactation time
for all children in another analysis, without any
signiﬁcant change of results (data not shown).
Of course, it would have been most appropri-
ate to have an estimate of in utero exposure,
but such data are lacking. To our knowledge,
no other common risk factors for testicular
cancer exist that should be adjusted for, e.g.,
smoking. Nevertheless, including smoking as a
covariant in the analysis did not change the
results significantly (data not shown). The
median concentration in the controls was used
as cutoff value in the calculations of ORs and
CIs, because no biological relevant cutoff
exists. The SAS program was also used for
descriptive statistics and Wilcoxon rank sum
tests for calculation of p-values.
Results
A total of 61 case and control pairs were
recruited. However, for technical reasons, we
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Table 1. Age distribution among cases, controls, and mothers of cases and controls.
No. Mean Median Minimum Maximum
Cases 58 31 30 18 45
Seminoma 22 34 33 23 45
Nonseminoma 36 29 29 18 42
Controls 61 32 31 19 47
Mothers of cases 44 57 54 41 75
Seminoma 14 60 61 48 75
Nonseminoma 30 55 54 41 69
Mothers of controls 45 57 55 43 75
Table 2. Concentrations of organochlorine compounds (nanograms per gram lipid) in cases with testicular
cancer and controls.
No. Mean Median Minimum Maximum p-Valuea
Sum of PCBs
Cases 58 395 357 96 1,099 0.91
Controls 61 394 364 110 1,083
HCB
Cases 58 26 24 5.3 58 0.33
Controls 61 24 22 8.8 47
p,p´-DDE
Cases 58 152 117 35 529 0.27
Controls 61 140 98 29 601
cis-Heptachlordane
Cases 58 2.1 1.2 0.2 13 0.30
Controls 61 1.3 1.0 0.3 9.3
cis-Chlordane
Cases 58 1.1 0.8 0.1 4.6 0.71
Controls 61 1.0 0.9 0.2 2.6
Oxychlordane
Cases 58 8.3 6.9 0.9 33 0.61
Controls 61 7.5 6.5 2.0 32
MC6
Cases 58 2.5 2.0 0.7 7.5 0.79
Controls 61 2.3 1.9 0.5 7.0
trans-Nonachlordane
Cases 58 8.6 7.5 1.6 28 0.87
Controls 61 8.5 7.9 0.9 26
cis-Nonachlordane
Cases 58 1.8 1.5 0.4 7.6 0.04
Controls 61 1.4 1.1 0.3 7.8
Sum of chlordanes
Cases 58 24 21 8.0 72 0.41
Controls 61 22 21 8.2 70
aWilcoxon p-value.
Table 3. OR (95% CI) for cases with testicular can-
cer, all types combined.a
Cases/controls OR (95% CI)
Sum of PCBs 28/30 1.1 (0.5–2.6)
HCB 35/30 1.7 (0.8–3.6)
p,p´-DDE 34/30 1.7 (0.8–3.7)
cis-Heptachlordane 34/29 1.6 (0.8–3.4)
cis-Chlordane 27/26 1.2 (0.6–2.6)
Oxychlordane 31/29 1.4 (0.7–2.9)
MC6 30/30 1.3 (0.6–2.9)
trans-Nonachlordane 27/30 1.0 (0.4–2.1)
cis-Nonachlordane 40/29 2.6 (1.2–5.7)
Sum of chlordanes 31/30 1.3 (0.6–2.8)
aThe median concentration of the chemicals in the con-
trols was used as cutoff value; numbers greater than the
median (expressed in nanograms per gram lipid) are
shown for cases and controls, and adjustment was made
for age and BMI.analyzed blood from only 58 cases. Of the case
mothers, 44 agreed to participate compared
with 45 of the control mothers.
Cases and controls. The 58 cases with tes-
ticular cancer were of mean age 31 years
(median 30, range 18–45), and the 61 con-
trols were of mean age 32 years (median 31,
range 19–47) (Table 1). Cases with semi-
noma were somewhat older than cases with
nonseminoma cancer, as was expected accord-
ing to the age distribution for these tumor
types.
The median number of birth order was
two for both the cases and controls (p = 0.27).
Median breast-feeding for the cases was
4 months (range 0–13.5) and for the controls
3 months (range 0–12; p = 0.49).
Of the cases, 22 had seminoma and 36 had
nonseminoma testicular cancer (28 embryonal
cancer and 8 teratoma).
Table 2 displays results on concentrations
of organochlorines for the sons. The only sig-
nificant difference was an increased concen-
tration of cis-nonachlordane in cases with
testicular cancer. This yielded OR = 2.6 (95%
CI, 1.2–5.7) if the median concentration
among the controls was used as cutoff value
(Table 3). Sum of PCBs did not differ
between cases and controls. For other studied
organochlorines, somewhat increased concen-
trations were found among the cases yielding
increased ORs, although not signiﬁcantly so.
Analysis according to histopathology gave
only significantly increased risk for cis-
nonachlordane among seminoma cases with
OR = 4.8 (95% CI, 1.4–16) (Table 4).
Mothers to cases and controls. Both groups
of mothers were of similar age overall,
although mothers to seminoma cases tended
to be somewhat older (Table 1). Median dura-
tion of breast-feeding in total before blood
sampling (all children including the studied
child) was 8 months both for case and control
mothers (p = 0.91).
Table 5 displays the results of concentra-
tions of organochlorines in mothers of cases
and controls. Signiﬁcantly increased concentra-
tions were found for the sum of PCBs, HCB,
trans-nonachlordane, cis-nonachlordane, and
sum of chlordanes.
Table 6 shows results of calculations of
OR and CI in the group of mothers. For sum
of PCBs, OR = 3.8 (95% CI, 1.4–10); for
HCB, OR = 4.4 (95% CI, 1.7–12); for trans-
nonachlordane, OR = 4.1 (95% CI, 1.5–11);
and for cis-nonachlordane, OR = 3.1 (95%
CI, 1.2–7.8). For cis-chlordane, a borderline
signiﬁcant result was obtained with OR = 2.5
(95% CI, 0.99–6.1). The other organochlo-
rines also yielded increased ORs, although not
signiﬁcantly so.
We made further calculations for mothers,
separated according to histopathology type of
the testicular cancer in the respective child
(Table 7). The results were similar to the
whole study group.
Discussion
The organochlorines studied are fat-soluble
chemicals that bioaccumulate in the human
body. The half-life for PCBs has been esti-
mated to be between 7 and 30 years in
human serum (Wolff et al. 1992). For p,p´-
DDE, the half-life in plasma is approximately
10 years (Hunter et al. 1997), and for chlor-
danes, half-life is 10–20 years (Dearth and
Hites 1991). For HCB, no half-life ﬁgure in
humans is documented.
Because of the long half-life, it would be
possible to estimate previous exposure by
measurement of lipid-based concentrations of
certain organochlorines. Because median time
from the fetal period until blood sampling was
similar for the cases (30 years) and for the con-
trols (31 years) in the data presented here, pre-
vious differences in exposure may be reﬂected
in current blood levels. Of course, there may be
individual differences in exposure and metabo-
lism patterns over the years, but we lack such
data. The results certainly indicate that further
studies are necessary, perhaps with a different
design, use of early blood samples if existing,
and the like. It cannot be completely excluded
that the real etiologic agent is something
unknown related to these factors. However, the
results for control mothers seem to be in rea-
sonable agreement with those found in another
study in Sweden (Hardell et al. 2001).
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Table 4. OR (95% CI) for cases with testicular cancer, seminoma, and nonseminoma, respectively.a
Seminoma Nonseminoma
Cases/controls OR (95% CI) Cases/controls OR (95% CI)
Sum of PCBs 13/30 1.1 (0.4–3.5) 15/30 1.1 (0.4–3.0)
HCB 14/30 1.6 (0.6–4.5) 21/30 1.8 (0.7–4.4)
p,p´-DDE 14/30 1.5 (0.5–4.5) 20/30 1.9 (0.8–4.7)
cis-Heptachlordane 12/29 1.4 (0.5–3.7) 22/29 2.1 (0.9–5.1)
cis-Chlordane 7/26 0.7 (0.2–1.9) 20/26 1.9 (0.8–4.7)
Oxychlordane 11/29 1.0 (0.4–2.8) 20/29 1.9 (0.8–4.7)
MC6 12/30 0.9 (0.3–2.7) 18/30 1.8 (0.7–4.9)
trans-Nonachlordane 11/30 0.7 (0.2–2.1) 16/30 1.2 (0.4–2.9)
cis-Nonachlordane 18/29 4.8 (1.4–16) 22/29 2.0 (0.8–4.7)
Sum of chlordanes 11/30 0.8 (0.3–2.4) 20/30 1.8 (0.7–4.4)
aThe median concentration of the chemicals in the controls was used as cutoff value; numbers greater than the median
(expressed in nanograms per gram lipid) are shown for cases and controls, and adjustment was made for age and BMI.
Table 5. Concentrations of organochlorine compounds (nanograms per gram lipid) in mothers of cases
with testicular cancer and controls.
No. Mean Median Minimum Maximum p-Valuea
Sum of PCBsb
Case mothers 43 859 792 236 2,114 0.0006
Control mothers 41 592 563 141 1,193
HCB
Case mothers 44 47 39 12 120 0.005
Control mothers 45 34 31 8.9 81
p,p´-DDE
Case mothers 44 566 315 109 3,339 0.48
Control mothers 45 428 324 51 1,431
cis-Heptachlordane
Case mothers 44 1.2 1.0 0.3 5.1 0.12
Control mothers 45 1.0 0.8 0.3 7.6
cis-Chlordane
Case mothers 44 0.9 0.7 0.2 7.9 0.24
Control mothers 45 0.7 0.7 0.2 1.5
Oxychlordane
Case mothers 44 14 10 1.9 50 0.24
Control mothers 45 10 9.4 1.4 32
MC6
Case mothers 44 5.1 4.2 0.7 13 0.09
Control mothers 45 3.6 3.8 0.6 7.8
trans-Nonachlordane
Case mothers 44 22 17 2.4 64 0.02
Control mothers 45 15 13 0.6 42
cis-Nonachlordane
Case mothers 44 1.8 1.3 0.4 9.2 0.008
Control mothers 45 1.1 1.0 0.4 2.8
Sum of chlordanes
Case mothers 44 46 34 14 131 0.04
Control mothers 45 32 31 5.8 76
aWilcoxon p-value. bOne case and four controls were not analyzed for certain PCB congeners because of technical reasons.Collection of blood was made during the
same period for cases and controls. In this way,
any change over time of organochlorines in the
population was eliminated. All blood was drawn
before treatment of the cases with chemotherapy
or radiotherapy to eliminate any potential inﬂu-
ence of treatment on the results. When a case
pair was recruited, a control subject was selected
at random in the same age group (5-year inter-
vals). Furthermore, as an inclusion criterion, the
control mother was in the same age group as the
respective case mother. The study was well bal-
anced for age in the case and control series.
BMI might inﬂuence the concentration of
organochlorines. Furthermore, the concen-
trations increase with age. All results were
adjusted for BMI and age (Hardell et al. 2001).
No subject reported occupational exposure
to the studied chemicals.
In this study, only one type of chlordane,
cis-nonachlordane, was signiﬁcantly increased
among the cases. Most other studied organo-
chlorines showed some but not significant
increases.
Interestingly, significantly increased con-
centrations were found among case mothers
for the sum of PCBs, HCB, cis-nonachlordane,
and the sum of chlordanes. Analysis according
to the histopathology of the sons (seminoma or
nonseminoma) yielded similar risk patterns.
Seminoma and nonseminoma both start as
carcinoma in situ (Skakkebæk et al. 1987).
Epidemiological studies (Andersen et al. 1999;
Møller 1989; Møller and Skakkebæk 1997;
Skakkebæk 1987) and biological evidence
(Jørgensen et al. 1995; Skakkebæk et al. 1987)
indicate that carcinoma in situ starts during the
fetal period. Thus, biologically it would be
relevant to study concentrations of endocrine
disruptors in the mothers.
The concentration of POPs in mothers’
milk reflects the body burden. Decreasing
concentrations of certain organochlorines
such as PCBs have been found in Swedish
breast milk since the 1980s. The highest con-
centrations were found in early 1970s (Norén
and Meironyté 1998). Because the median
age among the cases was 30 years, most of
them were born during the period with high
concentration in the population. Fetuses and
nursing infants receive significant exposures
to POPs as well as the largest body burdens
(Hooper and McDonald 2000). Prenatal and
lactation exposure appears to be an important
source of the adverse health effects of POPs
seen in infants, such as cognitive motor
deﬁcits (Patandin et al. 1999).
During lactation, the concentration of
POPs decreases in the mother (Lindström
1988; Lindström et al. 1994), but the period
when breast-feeding took place did not differ
for cases and controls. Furthermore, total time
of breast-feeding for all children was similar
among case and control mothers. In contrast,
higher concentrations of POPs give higher
exposure during breast-feeding in spite of sim-
ilar duration of breast-feeding. Because of the
long half-life for the studied chemicals, it is
postulated that the increased concentration
among the case mothers indicates higher expo-
sure during the fetal and postnatal period for
cases than for controls. One explanation for
the differences found would be if exposure to
POPs, mainly through the food chain, differs
later in life among case mothers.
In one study, neonates born to mothers
who were active smokers had highest PCB
and HCB concentrations compared with chil-
dren of mothers exposed to second-hand
smoke or nonsmoking mothers (Lackman et
al. 2000). However, in our study, smoking
habits in mothers did not change the results
(data not shown).
Some POPs, such as PCBs, especially the
hydroxylated metabolites, and chlordanes,
have been postulated to be endocrine dis-
ruptors (Andersen et al 1999; Andersson
et al. 1999; Willingham and Crews 1999;
Willingham et al. 2000). PCBs reverse
gonadal sex in turtle (Bergeron et al. 1994),
and abnormalities of reproductive develop-
ment has been described in juvenile alligators
living in a contaminated environment in
Florida (Guillette et al. 1994, 1996). HCB
has endocrine-disrupting properties (Colborn
et al. 1993). In addition, p,p´-DDE has been
postulated to be an environmental endocrine
disruptor (Willingham and Crews 1999). In
this study, no significant differences were
found for p,p´-DDE.
In summary, according to current hy-
potheses, testicular cancer is initiated during
the fetal period (Sharpe and Skakkebæk 1993;
Skakkebæk et al. 1987, 2001). Our results
show that the concentrations of certain POPs
are higher in mothers to patients with testicu-
lar cancer, but the etiologic significance of
this ﬁnding needs to be further explored.
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Table 6. OR (95% CI) for mothers of cases with tes-
ticular cancer, all types combined.a
Cases/controls OR (95% CI)
Sum of PCBsb 34/20 3.8 (1.4–10)
HCB 35/22 4.4 (1.7–12)
p,p´-DDE 22/22 1.3 (0.5–3.0)
cis-Heptachlordane 27/21 2.1 (0.8–5.0)
cis-Chlordane 22/15 2.5 (0.99–6.1)
Oxychlordane 28/22 2.6 (0.9–7.1)
MC6 25/22 1.3 (0.5–3.2)
trans-Nonachlordane 34/22 4.1 (1.5–11)
cis-Nonachlordane 32/22 3.1 (1.2–7.8)
Sum of chlordanes 27/22 1.9 (0.7–5.0)
aThe median concentration of the chemicals in the mothers
of controls was used as cutoff value; numbers greater than
the median (expressed in nanograms per gram lipid) are
shown for cases and controls, and adjustment was made for
age and BMI. bOne case and four controls were not analyzed
for certain PCB congeners because of technical reasons.
Table 7. OR and 95% CI for mothers of cases with testicular cancer, seminoma, and nonseminoma,
respectively.a
Seminoma Nonseminoma
Cases/controls OR (95% CI) Cases/controls OR (95% CI)
Sum of PCBb 11/20 3.1 (0.7–14) 23/20 4.3 (1.3–14)
HCB 10/22 2.1 (0.6–8.2) 25/22 9.0 (2.4–33)
p,p´-DDE 7/22 1.0 (0.3–3.7) 15/22 1.4 (0.5–4.0)
cis-Heptachlordane 9/21 3.2 (0.8–13) 18/21 1.8 (0.7–4.7)
cis-Chlordane 8/15 4.3 (1.1–17) 14/15 2.1 (0.7–5.7)
Oxychlordane 11/22 3.3 (0.7–16) 17/22 2.5 (0.8–7.9)
MC6 9/22 1.3 (0.4–5.0) 16/22 1.3 (0.5–3.6)
trans-Nonachlordane 10/22 1.9 (0.5–7.5) 24/22 5.6 (1.7–19)
cis-Nonachlordane 11/22 4.1 (0.96–18) 21/22 2.8 (1.01–7.8)
Sum of chlordanes 9/22 1.2 (0.3–4.8) 18/22 2.4 (0.8–7.3)
aAll control mothers used for comparison. The median concentration of the chemicals in the mothers of controls was used
as cutoff value; numbers greater than the median (expressed in nanograms per gram lipid) are shown for cases and con-
trols, and adjustment was made for age and BMI. bOne case and four controls were not analyzed for certain PCB congeners
because of technical reasons.Environmental Medicine | Hardell et al.
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